Comparison of the effects of troxerutin and heparinoid on flap necrosis

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 63, Issue 5, 2010, Pages 875-883

  Celik, Alper ^a   Ersoy, Omer F ^a   Ozkan, Namik ^a   Kayaoglu, Huseyin A ^a   Ozugurlu, Fikret ^a   Cakir, Ebru A ^b   Lordlar, Nese ^c   Omeroglu, Suna ^c  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b Education Hospital   (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Flap necrosis; Heparinoid; Nitric oxide; Troxerutin; Vascular endothelial growth factor

Indexed keywords

COLLAGEN; HEPARINOID; HIRUDOID FORTE; NITRIC OXIDE; TROXERUTIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; EDEMA; FIBROBLAST; FULL THICKNESS SKIN GRAFT; GRAFT NECROSIS; GRAFT SURVIVAL; GRANULATION TISSUE; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN CAPILLARY; SKIN FLAP; TISSUE NECROSIS; TREATMENT OUTCOME; WOUND CARE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; ANTICOAGULANTS; DISEASE MODELS, ANIMAL; FEMALE; FOLLOW-UP STUDIES; HEPARINOIDS; HYDROXYETHYLRUTOSIDE; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SKIN; SKIN TRANSPLANTATION; SPECTROPHOTOMETRY; SURGICAL FLAPS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASOCONSTRICTOR AGENTS; WOUND HEALING;

EID: 77950021161     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2009.01.082     Document Type: Article

References (44)

1. Ergun H., Cilingir M.G., Apaydin I., et al. The effect of dipyrone on survival of skin flaps. Scand J Plast Reconstr Surg Hand Surg 35 (2001) 19-22
2. Gatti J.E., Brousseau D.A., Silverman D.G., et al. Intravenous nitroglycerin as a means of improving ischemic tissue hemodynamics and survival. Ann Plast Surg 16 (1986) 521-526
3. Atalay C., Kockaya E.A., Cetin B., et al. Efficacy of topical nitroglycerin and transcutaneous electrical nerve stimulation on survival of random-pattern skin flaps in rats. Scand J Plast Reconstr Surg Hand Surg 37 (2003) 10-13
4. Smith D.K., and Dolan R.W. Effects of vasoactive topical agents on the survival of dorsal skin flaps in rats. Otolaryngol Head Neck Surg 121 (1999) 220-223
5. Aker J.S., Mancoll J., Lewis B., et al. The effect of pentoxifylline on random-pattern skin-flap necrosis induced by nicotine treatment in the rat. Plast Reconstr Surg 100 (1997) 66-71
6. Kerrigan C.L., and Daniel R.K. Pharmacologic treatment of failing skin flap. Plast Reconstr Surg 70 (1982) 541-548
7. Davis R.E., Wachholz J.H., Jassir D., et al. Comparison of topical anti-ischemic agents in the salvage of failing random pattern skin flaps in rats. Arch Facial Plast Surg 1 (1999) 27-32
8. Shalom A., and Westreich M. Effect of high dose and low dose aspirin on survival of random pattern flaps in rats. Scand J Plast Reconstr Surg Hand Surg 35 (2001) 117-121
9. Nakanishi Y., Nakajima T., Yoshimura Y., et al. The transepidermal absorption of prostaglandin E1 as a topical ointment: An experimental study of application over a rat skin flap. Ann Plast Surg 40 (1998) 44-47
10. Kjartansson J., and Lundeberg T. Effects of electrical nerve stimulation (ENS) in ischemic tissue. Scand J Plast Reconstr Surg Hand Surg 24 (1990) 129-134
11. Schipper J., Ridder G.J., Maier W., et al. The preconditioning and prelamination of pedicled and free microvascular anastomised flaps with the technique of vacuum assisted closure. Laryngorhinootologie 82 (2003) 421-427
12. Mehta P.P., Sagar S., Kakkar V.V., et al. Treatment of superficial thrombophlebitis: a randomized double-blind trial of heparinoid cream. Br Med J 3 (1975) 614-616
13. Kuisma I., and Tamelander G. Mucopolysaccharide polysulphate cream in the prevention of pressure sores - a double blind study. Ann Clin Res 19 (1987) 374-377
14. Larsson B., Fianu S., Jonasson A., et al. Percutaneous treatment with a mucopolysaccharide polysulphate of experimentally induced subcutaneous haematomas in man. Thromb Haemost 53 (1985) 343-345
15. Westerhof W., Das P.K., Middelkoop E., et al. Mucopolysaccharides from psyllium involved in wound healing. Drugs Exp Clin Res 27 (2001) 165-175
16. Stüttgen G., Panse P., Bauer E., et al. Permeation of the human skin by heparin and mucopolysaccharide polysulfuric acid ester. Arzneimittelforschung/Drug Res 40 (1990) 484-489
17. Hoppensteadt D.A., Fareed J., Raake P., et al. Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulphate to non-human primates. Thromb Res 103 (2001) 157-163
18. Rekka E., and Kourounakis P.N. Effect of hydroxyethyl rutisodes and related compounds on lipid peroxidation and free radical scavenging activity. J Pharm Pharmacol 43 (1991) 486-491
19. Di Carlo A., Passi S., Ippolito F., et al. Free radical scavenger activity of rutosides. Minerva Cardioangiol 50 (2002) 701-707
20. van Acker S.A., van Balen G.P., van den Berg D.J., et al. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol 56 (1998) 935-943
21. Park Y.C., Rimbach G., Saliou C., et al. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett 465 (2000) 93-97
22. Adam B.S., Pentz R., Siegers C.P., et al. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin. Phytomedicine 12 (2005) 52-61
23. Patwardhan A., Carlsson K., Poullain J.C., et al. The affinity of troxerutin for the venous wall measured by laser scanning microscopy. J Cardiovasc Surg 36 (1995) 381-385
24. Krupinski K., Giedrojc J., Bielawiec M., et al. Effect of troxerutin on laser induced thrombus formation in rat mesenteric vessels, coagulation parameter and platelet function. Pol J Pharmacol 48 (1996) 335-339
25. Boisseau M.R., Taccoen A., Garreau C., et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency. J Cardiovasc Surg 36 (1995) 369-374
26. Price M.A., and Pearl R.M. Multiagent pharmacotherapy to enhance skin flap survival: lack of addictive effect on nitroglycerine and allopurinol. Ann Plast Surg 33 (1994) 52-56
27. Bayat M., Chelcheraghi F., Piryaei A., et al. The effect of 30-day pretreatment with pentoxifylline on the survival of a random skin flap in the rat: An ultrastructural and biomechanical evaluation. Med Sci Monit 12 (2006) 201-207
28. Bories P.N., and Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41 (1995) 904-907
29. Gilliam M.B., Sherman M.P., Griscavage J.M., et al. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem 212 (1993) 359-365
30. Yuksel H., Kose C., Yilmaz O., et al. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component. Clin Exp Allergy 37 (2007) 1183-1188
31. Kessler M., Ubeaud G., Walter T., et al. Free radical scavenging and skin penetration of troxerutin and vitamin derivatives. J Dermatolog Treat 13 (2002) 133-141
32. Parodi M.B. Medical treatment of retinal vein occlusions. Semin Ophthalmol 19 (2004) 43-48
33. Basile M., Gidaro S., Pacella M., et al. Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study. Curr Med Res Opin 17 (2001) 256-261
34. Petruzzellis V., Troccoli T., Candiani C., et al. Oxerutins (Venoruton): efficacy in chronic venous insufficiency-a double-blind, randomized, controlled study. Angiology 53 (2002) 257-263
35. Cesarone M.R., Incandela L., De Sanctis M.T., et al. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. J Cardiovasc Pharmacol Ther 7 (2002) 21-24
36. Incandela L., Cesarone M.R., DeSanctis M.T., et al. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized study. J Cardiovasc Pharmacol Ther 7 (2002) 11-15
37. Senger D.R., Connolly D.T., Van de Water L., et al. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50 (1990) 1774-1778
38. Lubiatowski P., Goldman C.K., Gurunluoglu R., et al. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 109 (2002) 1986-1993
39. Khan A., Ashrafpour H., Huang N., et al. Acute local subcutaneous VEGF-165 injection for augmentation of skin flap viability: efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol 287 (2004) 1219-1229
40. Krum J.M., Mani N., Rosenstein J.M., et al. Angiogenic and astroglial response to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110 (2002) 589-604
41. Ashrafpour H., Huang N., Neligan P.C., et al. Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol 286 (2004) 946-955
42. Autore G., Rastrelli L., Lauro M.R., et al. Inhibition of nitric oxide synthase expression by a methanolic extract of Crescentia alata and its derived flavonols. Life Sci 70 (2001) 523-534
43. Chen Y.C., Shen S.C., Lee W.R., et al. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J Cell Biochem 82 (2001) 537-548
44. Chung H.K., Choi S.M., Ahn B.O., et al. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittel-Forschung 55 (2005) 573-580